FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells
Chor-Fung Ng(Chinese University of Hong Kong), Stephen Kwok‐Wing Tsui(Chinese University of Hong Kong), Vivian Wai Yan Lui(Chinese University of Hong Kong), Kwok‐Pui Fung(Chinese University of Hong Kong), Judy Yuet‐Wa Chan(Chinese University of Hong Kong), Patrick Kwok‐Shing Ng(The University of Texas MD Anderson Cancer Center), Paul B.S. Lai(Chinese University of Hong Kong), Jialiang Li(Singapore Eye Research Institute), Yuen‐Keng Ng(Augusta University)
Cited by 36
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
|Proceedings of the National Academy of Sciences|2015|818
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
|Proceedings of the National Academy of Sciences|2015|770